Recro Pharma, Inc.
REPH
Price:
$2.09
Market Cap:
$116.13M
Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2014-03-07
Stock Exchange
NASDAQ
Ticker
REPH
PE Ratio
[-8.04]
ROE
[-22.40%]
Current Ratio
[1.07]
Dividend Yield
[0%]
Enterprise Value
[189.40M]
Dividend History
The ROE as of June 2025 (TTM) for Recro Pharma, Inc. (REPH) is -22.40%
According to Recro Pharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -22.40%. This represents a change of 281.21% compared to the average of -5.88% of the last 4 quarters.
Recro Pharma, Inc. (REPH) Historical ROE (quarterly & annually)
How has REPH ROE performed in the past?
The mean historical ROE of Recro Pharma, Inc. over the last ten years is 90.01%. The current -22.40% ROE has changed -124.89% with respect to the historical average. Over the past ten years (40 quarters), REPH's ROE was at its highest in in the December 2018 quarter at 211.78%. The ROE was at its lowest in in the September 2018 quarter at -97.85%.
Average
90.01%
Median
-27.92%
Minimum
-173.60%
Maximum
572.65%
Recro Pharma, Inc. (REPH) ROE by Quarter and Year
Discovering the peaks and valleys of Recro Pharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 311.59%
Maximum Annual ROE = 572.65%
Minimum Annual Increase = -661.12%
Minimum Annual ROE = -173.60%
| Year | ROE | Change |
|---|---|---|
| 2023 | -22.63% | -31.87% |
| 2022 | -33.21% | -47.29% |
| 2021 | -63.01% | -119.04% |
| 2020 | 330.92% | -42.21% |
| 2019 | 572.65% | 40.07% |
| 2018 | 408.84% | -335.51% |
| 2017 | -173.60% | 311.59% |
| 2016 | -42.18% | -661.12% |
| 2015 | 7.52% | -108.82% |
| 2014 | -85.24% | -99.90% |
Recro Pharma, Inc. (REPH) Average ROE
How has REPH ROE performed in the past?
The current ROE of Recro Pharma, Inc. (REPH) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-39.62%
5-year avg
156.94%
10-year avg
90.01%
Recro Pharma, Inc. (REPH) ROE vs. Peers
How is REPH’s ROE compared to its peers?
Recro Pharma, Inc.’s ROE is
| Company | ROE | Market cap |
|---|
Build a custom stock screener for Recro Pharma, Inc. (REPH) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Recro Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Recro Pharma, Inc. (REPH) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Recro Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Recro Pharma, Inc.'s ROE?
How is the ROE calculated for Recro Pharma, Inc. (REPH)?
What is the highest ROE for Recro Pharma, Inc. (REPH)?
What is the 3-year average ROE for Recro Pharma, Inc. (REPH)?
What is the 5-year average ROE for Recro Pharma, Inc. (REPH)?
How does the current ROE for Recro Pharma, Inc. (REPH) compare to its historical average?